H. Lundbeck A/s (OTC: HLUYY)

H. Lundbeck A/s Return vs. S&P

H. Lundbeck A/s Company Info

H. Lundbeck A/S engages in the research, development, production and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. It operates through the following geographical segments: Europe, North America, and International Markets. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.

Valuation